Mechanisms restricting hepatitis B virus cross-species transmission
mBio · 08.07.2026 · 17 (7)
DOI: 10.1128/mbio.03763-25 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift mBio, erschienen am 08.07.2026. Verfasst von Jenny N Ijoma und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology, Princeton University, Princeton, New Jersey, USA. Hauptthemen laut MEDLINE: Hepatitis B virus, Host Specificity, Hepatitis B, Chronic, Viral Tropism. Die Arbeit nennt 115 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases, Open Philanthropy Project.
Abstract (Originalsprache)
Chronic hepatitis B virus (HBV) infection affects more than 250 million people worldwide and markedly increases the risk of terminal liver diseases, including liver cirrhosis and hepatocellular carcinoma. Despite its global impact, HBV exhibits a remarkably narrow host range, with natural infection largely restricted to humans and chimpanzees. This stringent tropism has posed a major barrier to the development of experimentally tractable in vivo models and has limited our ability to study viral persistence, pathogenesis, and immune control. Over the past decades, substantial progress has been made in identifying the host and viral factors that govern HBV species specificity. Efforts to overcome these constraints have led to the development of genetically engineered systems, the use of surrogate hepadnaviruses that naturally infect other species, and the establishment of humanized liver models that enable infection in vivo within a human hepatocyte context. While these approaches have provided important insights, no currently available model fully recapitulates chronic HBV infection in an immunocompetent host. Defining and overcoming the barriers that underlie HBV’s restricted host range remains a central challenge in the field. Addressing this limitation will be essential for establishing physiologically relevant model systems and, ultimately, for enabling the development of curative strategies for chronic hepatitis B.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Molecular Biology, Princeton University, Princeton, New Jersey, USA.
ORCID-Profile: Jenny N Ijoma, Alexander Ploss
Förderung
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
- Open Philanthropy Project
- Fifth Generation, Inc.
- Princeton University
- New Jersey Commission on Cancer Research
Zitieren
APA
Ijoma, J. N., Gomez-Moreno, A., Ayoub, S., & Ploss, A. (2026). Mechanisms restricting hepatitis B virus cross-species transmission. mBio, 17(7). https://doi.org/10.1128/mbio.03763-25
Vancouver
Ijoma JN, Gomez-Moreno A, Ayoub S, Ploss A. Mechanisms restricting hepatitis B virus cross-species transmission. mBio. 2026;17(7). doi:10.1128/mbio.03763-25
BibTeX
@article{Ijoma2026,
author = {Ijoma, Jenny N and Gomez-Moreno, Andoni and Ayoub, Samer and Ploss, Alexander},
title = {Mechanisms restricting hepatitis B virus cross-species transmission},
journal = {mBio},
year = {2026},
volume = {17},
number = {7},
doi = {10.1128/mbio.03763-25}
}
EUVIMED